Companies Dominating the Blood Screening Landscape
- Abbott Laboratories
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Grifols, S.A.
- Quotient Limited
- Thermo Fisher Scientific Inc.
- BD
- Ortho Clinical Diagnostics
- DiaSorin S.p.A.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Beckman Coulter, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Blood Screening Market in 2025 is evaluated at USD 3.16 billion.
The global market size was worth over USD 3 billion in 2024 and is poised to grow at a CAGR of around 6.5%, reaching USD 6.8 billion revenue by 2037.
North America is likely to bring in USD 2.58 billion by 2037, fueled by higher demand for blood transfusion and the presence of a strong healthcare network in the region.
The major players in the market include Abbott Laboratories, Grifols, S.A., Quotient Limited, Thermo Fisher Scientific Inc., BD, Ortho Clinical Diagnostics, DiaSorin S.p.A., Bio-Rad Laboratories, Inc., Danaher Corporation, Beckman Coulter, Inc.
